These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6439167)

  • 21. [Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
    Lanza GA; Tamburi S; Mondello Malvestiti FM; Rebuzzi AG; Lucente M
    Cardiologia; 1988 Jun; 33(6):613-8. PubMed ID: 3139292
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of flecainide in the treatment of ventricular arrhythmia].
    Hug C; Koliopoulos N; Tardy C; Errera J; Puech P
    Ann Cardiol Angeiol (Paris); 1983 May; 32(3):161-4. PubMed ID: 6193751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Amiodarone (Cordarone). A very effective anti-arrhythmia agent with many side-effects].
    Aldershvile J; Abildgaard U; Hansen PF
    Ugeskr Laeger; 1986 Apr; 148(18):1101-2. PubMed ID: 3727078
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical study of injectable amiodarone in arrhythmia].
    Warembourg H; Ducloux G
    Lille Med; 1976 Dec; 21 Suppl 4():908-10. PubMed ID: 1018616
    [No Abstract]   [Full Text] [Related]  

  • 25. Symposium on flecainide acetate.
    Am J Cardiol; 1984 Feb; 53(5):1B-122B. PubMed ID: 6695812
    [No Abstract]   [Full Text] [Related]  

  • 26. Flecainide: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP; Tilley-Gray B
    Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
    Manning AS; Bruyninckx C; Ramboux J; Chatelain P
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):453-61. PubMed ID: 8583788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone for cardiac arrhythmias. Key management issues for NPs.
    McLemore R
    Adv Nurse Pract; 2001 Apr; 9(4):69-71. PubMed ID: 12420439
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug therapy. Flecainide.
    Roden DM; Woosley RL
    N Engl J Med; 1986 Jul; 315(1):36-41. PubMed ID: 3520324
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy of tachyarrhythmias, benefits and risks. Proceedings of a symposium. Düsseldorf, 11 July 1984.
    Drugs; 1985; 29 Suppl 4():1-88. PubMed ID: 4006775
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B
    Clin Ter; 1983 Apr; 105(1):3-11. PubMed ID: 6189663
    [No Abstract]   [Full Text] [Related]  

  • 32. More on amiodarone for ventricular tachyarrhythmias.
    Nademanee K; Singh BH
    N Engl J Med; 1982 May; 306(19):1175. PubMed ID: 7070422
    [No Abstract]   [Full Text] [Related]  

  • 33. New antiarrhythmic agents.
    Pepper GA
    Nurse Pract; 1986 Jul; 11(7):62-4, 67, 70. PubMed ID: 3737022
    [No Abstract]   [Full Text] [Related]  

  • 34. Human electrophysiology: mechanisms of arrhythmia prevention and the action of amiodarone.
    Campbell RW; Cowan JC
    Br J Clin Pract Suppl; 1986 Apr; 44():99-103. PubMed ID: 3089268
    [No Abstract]   [Full Text] [Related]  

  • 35. [Flecainide in the treatment of chronic ventricular arrhythmia].
    Raviele A; Piccolo E
    G Ital Cardiol; 1985 Mar; 15(3):283-4. PubMed ID: 4018466
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful use of an intravenous infusion of flecainide and amiodarone for a refractory combination of postoperative junctional and ectopic tachycardias.
    Haas NA; Fox S; Skinner JR
    Cardiol Young; 2005 Aug; 15(4):427-30. PubMed ID: 16014194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amiodarone--application and clinical pharmacology in atrial fibrillation and other arrhythmias.
    Anastasiou-Nana M; Levis GM; Moulopoulos SD
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):229-35. PubMed ID: 6746145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electrocardiographic effects and antiarrhythmic action of 1200 mg of oral amiodarone per day].
    Tonet JL; Lechat P; Frank R; Lascault G; Fontaine G; Facquet J; Cohen A; Grosgogeat Y
    Ann Cardiol Angeiol (Paris); 1984; 33(5):309-15. PubMed ID: 6476769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical use of intravenous amiodarone for supraventricular arrhythmias].
    Assadi S; Edoute Y
    Harefuah; 1995 Dec; 129(12):583-6. PubMed ID: 8682364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.